China To Fund API Makers To Promote Exports
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Chinese government will spend RMB 5 billion ($760 million) to upgrade drug manufacturing quality assurance in an effort to help active pharmaceutical ingredient makers comply with global good manufacturing practices so they can export to the U.S. and Europe, an unnamed government official told the Shanghai Securities News